MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
| Image |  |
|---|---|
| Description | scientific article published on 17 February 2014 |
| Author/s |
author: Andrea Rubbert-Roth Igor A Zupanets Vadym Y Berenfus Dmitriy Rekalov Mariusz Korkosz Piotr Wiland |
| Publication date | February 17, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |